CLEVELAND — More than 200,000 Ohioans suffer from Alzheimer’s disease, but Cleveland Clinic researchers may have discovered a way to reduce that number by repurposing an already approved FDA drug.
At the time, Ann says there were no treatment options, but then in 2020, they got a call from the Cleveland Clinic about a clinical trial. “We wanted to further validate our findings using two independent larger patient databases,” said Feixiong.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: WebMD - 🏆 709. / 51 Read more »